When exposed to iohexol, stable CAD patients with DM (group II) were more likely to release more CD31+/CD41a− EMPs and PMPs than patients without DM (group III) (Figures 1(b) and 1(d)). This evidence concerns the gene PECAM1 and diabetes mellitus.